TSIDEM02:	Subjects by Region, Country/Territory, and Site; Full Analysis Set (Study jjcs - core)					
Region 	Active Study Agent 	Active Study Agent 	 	 	
  Country/Territory 	Xanomeline High Dose 	Xanomeline Low Dose 	Placebo 	Total 	
    Site, n (%) 	N=64 	N=62 	N=59 	N=185 	
NA 	64 (100.0%) 	62 (100.0%) 	59 (100.0%) 	185 (100.0%) 	
United States of America 	64 (100.0%) 	62 (100.0%) 	59 (100.0%) 	185 (100.0%) 	
701 	12 (18.8%) 	12 (19.4%) 	11 (18.6%) 	35 (18.9%) 	
702 	0 	1 (1.6%) 	0 	1 (0.5%) 	
703 	4 (6.2%) 	5 (8.1%) 	5 (8.5%) 	14 (7.6%) 	
704 	6 (9.4%) 	7 (11.3%) 	6 (10.2%) 	19 (10.3%) 	
705 	5 (7.8%) 	3 (4.8%) 	2 (3.4%) 	10 (5.4%) 	
706 	0 	1 (1.6%) 	0 	1 (0.5%) 	
707 	0 	0 	1 (1.7%) 	1 (0.5%) 	
708 	6 (9.4%) 	6 (9.7%) 	4 (6.8%) 	16 (8.6%) 	
709 	4 (6.2%) 	5 (8.1%) 	6 (10.2%) 	15 (8.1%) 	
710 	8 (12.5%) 	7 (11.3%) 	7 (11.9%) 	22 (11.9%) 	
711 	1 (1.6%) 	1 (1.6%) 	1 (1.7%) 	3 (1.6%) 	
713 	1 (1.6%) 	2 (3.2%) 	3 (5.1%) 	6 (3.2%) 	
714 	2 (3.1%) 	2 (3.2%) 	2 (3.4%) 	6 (3.2%) 	
715 	2 (3.1%) 	2 (3.2%) 	1 (1.7%) 	5 (2.7%) 	
716 	8 (12.5%) 	4 (6.5%) 	7 (11.9%) 	19 (10.3%) 	
717 	2 (3.1%) 	1 (1.6%) 	1 (1.7%) 	4 (2.2%) 	
718 	3 (4.7%) 	3 (4.8%) 	2 (3.4%) 	8 (4.3%)